These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12352803)

  • 21. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal age for vaccination against measles in the State of São Paulo, Brazil, taking into account the mother's serostatus.
    Zanetta RA; Amaku M; Azevedo RS; Zanetta DM; Burattini MN; Massad E
    Vaccine; 2001 Oct; 20(1-2):226-34. PubMed ID: 11567768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].
    Poethko-Müller C; Mankertz A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1243-52. PubMed ID: 23990086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Must we expect an epidemic of measles in the near future in Southern Tyrol?].
    Kreidl P; Morosetti G
    Wien Klin Wochenschr; 2003; 115 Suppl 3():55-60. PubMed ID: 15508782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress toward measles elimination in the People's Republic of China, 2000-2009.
    Ma C; An Z; Hao L; Cairns KL; Zhang Y; Ma J; Cao L; Wen N; Xu W; Liang X; Yang W; Luo H
    J Infect Dis; 2011 Jul; 204 Suppl 1():S447-54. PubMed ID: 21666198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS; Nokes DJ
    Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles control efforts in urban Africa complicated by high incidence of measles in the first year of life.
    Taylor WR; Mambu RK; ma-Disu M; Weinman JM
    Am J Epidemiol; 1988 Apr; 127(4):788-94. PubMed ID: 3354544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interruption of indigenous measles transmission in Bolivia since October 2000.
    Quiroga R; Barrezueta O; Venczel L; Halkyer P; Gil F; Machicao E; Landaverde M; Quiñonez A; Izurieta H
    J Infect Dis; 2003 May; 187 Suppl 1():S121-6. PubMed ID: 12721902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of measles vaccine during the 1993 measles epidemic in Korea.
    Kim SK; Son BK; Chung CY; Ahn YM; Park CY; Lee HJ
    Pediatr Infect Dis J; 1995 May; 14(5):346-9. PubMed ID: 7638007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of Australia's measles control programme over the past decade.
    Gidding HF
    Epidemiol Infect; 2005 Feb; 133(1):99-105. PubMed ID: 15724716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M; Kanra G; Erdem G; Kanra B
    Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunization against measles in the GDR and current results of the program to combat measles].
    Starke G; Gerike E; Hlinak P
    Z Gesamte Hyg; 1980; 26(12):881-5. PubMed ID: 7234002
    [No Abstract]   [Full Text] [Related]  

  • 40. [Risk factors for delayed or missed measles vaccination in young children].
    Schönberger K; Grote V; von Kries R; Kalies H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Nov; 52(11):1045-51. PubMed ID: 19795100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.